Sector
PharmaceuticalsOpen
₹1,034Prev. Close
₹1,014.55Turnover(Lac.)
₹276.01Day's High
₹1,069.9Day's Low
₹1,00752 Week's High
₹1,14052 Week's Low
₹483.1Book Value
₹255.43Face Value
₹10Mkt Cap (₹ Cr.)
1,100.29P/E
27.59EPS
38.44Divi. Yield
06 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
6 Sep 2024
12:00 AM
AGM
Announcement Date: 06 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 10.38 | 10.38 | 10.38 | 10.38 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 215.57 | 191.65 | 172.18 | 52.13 |
Net Worth | 225.95 | 202.03 | 182.56 | 62.51 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 261.5 | 138.68 | 165.15 | 136.82 |
yoy growth (%) | 88.56 | -16.02 | 20.7 | 43.54 |
Raw materials | -165.59 | -87.07 | -119.34 | -101.28 |
As % of sales | 63.32 | 62.78 | 72.26 | 74.02 |
Employee costs | -15.67 | -11.68 | -8.42 | -5.53 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 21.79 | 11.14 | 10.89 | 7.55 |
Depreciation | -6.43 | -4.39 | -3.05 | -2.85 |
Tax paid | -6.38 | -2.7 | -3.34 | -2.87 |
Working capital | 3.88 | 11.55 | 1.1 | 6.11 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 88.56 | -16.02 | 20.7 | 43.54 |
Op profit growth | 107.32 | -7.37 | 32.62 | 34.55 |
EBIT growth | 78.98 | 4.05 | 34.65 | 26.66 |
Net profit growth | 82.82 | 11.71 | 61.4 | 35.96 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 370.2 | 307.17 | 251.03 | 456.19 | 262.01 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 370.2 | 307.17 | 251.03 | 456.19 | 262.01 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.92 | 1.83 | 2.94 | 3.51 | 1.59 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,688 | 94.57 | 4,05,007.74 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,657.95 | 80.01 | 1,76,747.65 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,502.75 | 25.22 | 1,21,378.29 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,344.4 | 59.4 | 1,13,184.61 | 474 | 0.96 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,301.15 | 20.3 | 1,08,591.61 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Ramesh Arora
Whole-time Director
Ajay Arora
Independent Director
Ravi Shanker Singh
Whole-time Director
Geeta Arora
Whole-time Director
Anju Arora
Whole Time Director & CFO
Aditya Arora
Independent Director
Pankaj Takkar
Independent Director
Kiran Kumar Verma
Company Sec. & Compli. Officer
Gurpreet Kaur
Independent Director
Kartik Kapur
Independent Director
Prashanth Vellanki
Village Nagkalan,
Majitha Road,
Punjab - 143601
Tel: 91-183-2774321-25
Website: http://www.kwalitypharma.com
Email: cs@kwalitypharma.com
E-2/3 Ansa Indl Est,
Saki Vihar Road, Sakinaka Andheri(E),
Mumbai - 400072
Tel: 91-22-40430200/28470
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinn...
Read More
Reports by Kwality Pharmaceuticals Ltd
What is the Kwality Pharmaceuticals Ltd share price today?
What is the Market Cap of Kwality Pharmaceuticals Ltd?
What is the PE and PB ratio of Kwality Pharmaceuticals Ltd?
What is the 52 Week High and Low of Kwality Pharmaceuticals Ltd?
What is the CAGR of Kwality Pharmaceuticals Ltd?
What is the shareholding pattern of Kwality Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.